Business Wire: Merck announces supply agreement with U.S. government for molnupiravir, an investigational oral antiviral candidate for treatment of mild to moderate COVID-19

Business Wire | June 9, 2021

Print

Tags »

Molnupiravir and Drug Development at Emory